About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

view more

 

CRO

  • check

    Needs Discuss

  • check

    Quote and Ordar

  • check

    Timetable Schedule

  • check

    Report Launch

  • done

    Case Closed

view more

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

台灣科技發展基金會與麥德凱生科合作,推進AI技術在健康生活與保健產品開發領域的應用。

 

在人工智慧(AI)浪潮席捲全球之際,台灣生技產業也迎來了嶄新的發展契機。(財團法人台灣科技發展基金會TSTDF)與(麥德凱生科MDG)日前宣布建立策略合作夥伴關係,雙方將攜手推進AI 技術在健康生活與保健產品開發領域的應用,為台灣生技產業注入強勁動能。TSTDF 董事長楊揚表示,AI 技術正以前所未有的速度重塑全球健康產業,台灣在生醫科技領域擁有深厚的基礎,透過與AI 技術深度融合,有望在個人健康管理、疾病預防、精準保健等領域,取得突破性進展。「我們的目標是將台灣打造為全球智慧保健與AI 保健技術的領航者。」

 

麥德凱生科總經理洪志駿表示,與TSTDF 的合作將進一步強化麥德凱生科在AI 驅動生醫技術研發方面的實力,並加速其國際市場的拓展。

📢 立即閱讀完整新聞報導:

     經濟日報報導>商情>綠色商機大趨勢

 

#AI #生技產業 #健康科技 #麥德凱生科 #TSTDF #台灣科技發展基金會

 

 tstdf copy